Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA   US0400471027

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Arena Pharmaceuticals, Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales16,612,727,682,795,4166
Operating income (EBITDA)-83,8-71,7-67,4-37,0-14,611,2
Operating profit (EBIT)-96,4-82,8-76,5-27,7-27,229,5
Pre-Tax Profit (EBT)--111-85,5---
Net income-125-111-88,3-32,5-41,413,8
EPS ( $)-1,14-0,80-0,45-0,14-0,180,06
Dividend per Share ( $)------
Yield------
Announcement Date03/11/2011
12:00pm
03/14/2012
08:02pm
03/04/2013
12:01pm
---
Finances - Leverage
Arena Pharmaceuticals, Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance103-----
Operating income (EBITDA)-83,8-71,7-67,4-37,0-14,611,2
Leverage
(Debt/EBITDA)
------
Capital Expenditure4,210,621,781,873,503,50
Book Value Per Share (BVPS)0,66 $-0,45 $0,39 $0,76 $1,01 $
Cash Flow per Share-0,48 $-0,56 $-0,22 $0,06 $--
Announcement Date03/11/2011
12:00pm
03/14/2012
08:02pm
03/04/2013
12:01pm
---
Balance Sheet Analysis
Arena Pharmaceuticals, Inc : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 1 740 M$ -
Company Value - 1 740 M$
Valuation 2013e 2014e
PER (Price / EPS)
Capitalization / Revenue 21,0x 18,2x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) -33,5% -28,5%
operating laverage (Delta EBIT / Delta Sales) 0,32x 0,12x
Net Margin (Net Profit / Revenue) -39,3% -43,4%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -12,6% -
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   2,26% 3,67%
Cash Flow / Sales (Taux d'autofinancement) 15,8% -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
Arena Pharmaceuticals, Inc : Price Earning Ratio
EPS & Dividend
Arena Pharmaceuticals, Inc : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.